MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 21 - per page Next page
Order by
"It bothers me that I asked my daughter if she would take the clothes home with her to put them in her dryer. After she left I realised that I have my own dryer that I have been using for the past three years." More
In 2004, Worldwide Business Research and Pharmalicensing jointly awarded Endo Pharmaceuticals and Vernalis the BioBusiness Network Innovative Partnership 2004 award More
Bipolar disorder—the disease previously known as manic depression—does not capture the lay or medical headlines to the same extent as schizophrenia More
Alzheimer's disease (AD), widely regarded as the most common cause of dementia, is a progressive neurological disorder. It can result in symptoms like memory loss, personality alterations and difficulty in communicating and performing routine tasks. More
DrugAbuse Sciences was founded to improve the treatment of alcohol and drug addictions/dependence through the discovery, development, and commercialization of innovative and cost-effective medications. More
In terms of world-wide sales, the current antidepressant of choice is the selective serotonin re-uptake inhibitor (SSRI) More
Ester Neurosciences is developing a unique, disease-modifying approach to combat neurological disorders that result from disrupted acetlycholinesterase (AChE) neuromodulation More
A neuroscience company focused on developing novel drugs for the treatment of CNS disorders, Amarin's lead product, MiraxionTM, is in development for Huntington's disease and treatment-unresponsive depression More
With many treatments available, the pipeline for new drugs to treat this enigmatic disease is thin. More
GB Therapeutics is at the forefront of nitric oxide therapeutics research and application, having created novel nitrate drugs for the treatment of CNS and cardiovascular disorders. More
Displaying 1..10 of 21 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us